Bio-Rad Laboratories expects to recover 25% of the revenue shortfall resulting from the cyber-attack it suffered in Q4. The US research and clinical diagnostic reagents firm made the prediction during a conference call this week. CFO Ilan Daskal told analysts “Fourth quarter revenue fell short by about $20 million from the midpoint of our guidance, mainly due to the cyber-attack that we reported in early December. He added, “We expect to recover in Q1 of 2020 about $5 million of…
Eppendorf has launched the SciVario bioreactor control system, which it says allows constant monitoring of two vessels at the same time. The SciVario twin control system, compatible with Eppendorf’s range of bioreactors, fermenters and single-use vessels, aims to help drug developers and researchers by providing a flexible controller to help adapt to changing requirements in a laboratory. “The controller was designed in a compact way to control two vessels in parallel to save space on the bench, but at the…
MukoCell GmbH has hired Co.don AG to manufacture its autologous cell-based treatment for urological disorders. The deal will see Co.don make the product – also named MukoCell – at its recently established human cell-focused manufacturing facility in Leipzig, Germany. Matthias Meißner, Co.don director of corporate communications, told us MukoCell “is an innovative and gentle method for the surgical repair of urethral strictures.” A urethral stricture is a narrowing of the urethra caused by injury, instrumentation, infection, and certain non-infectious forms of urethritis. MukoCell…